Annals of Vascular Diseases: 2023, vol: 16, issue: 1
1)- Seiji Onitsuka, Hiroyuki Ito. Surgical Treatment of Sac Enlargement Due to Type II Endoleaks Following Endovascular Aneurysm Repair.Annals of vascular diseases. 2023, 16 (1): 1-7
2)- Hironori Kobayashi, Kitae Kim, Yutaka Furukawa. Impact of the Concurrent Acute Illness on the Short-Term Prognosis in Patients with Hemodynamically Stable Acute Pulmonary Embolism.Annals of vascular diseases. 2023, 16 (1): 24-30
4)- Kazunori Horie, Akiko Tanaka, Masataka Taguri, Norio Tada. Single-Center Contemporary Clinical Outcomes after Endovascular Treatment in Patients with De Novo Femoropopliteal Lesions between 2017 and 2019.Annals of vascular diseases. 2023, 16 (1): 38-45
7)- Daichi Arakaki, Mitsunaga Iwata, Teruhiko Terasawa. External Validation of the Padua and IMPROVE-VTE Risk Assessment Models for Predicting Venous Thromboembolism in Hospitalized Adult Medical Patients: A Retrospective Single-Center Study in Japan.Annals of vascular diseases. 2023, 16 (1): 60-68
9)- Carlos A Hinojosa, Javier E Anaya-Ayala, Hugo Laparra-Escareno, Lourdes Mena-Hernandez, Rodrigo Barquera, Jose I MartÃnez-Quesada, Julio Granados. Takayasu's Arteritis in Mexican Monozygotic Twins: Analysis of Human Leukocyte Antigens (HLA) Haplotypes.Annals of vascular diseases. 2023, 16 (1): 73-76
11)- Motoaki Sano. Complexity of Inflammation in the Trajectory of Vascular Disease: Interleukin 6 and Beyond.Annals of vascular diseases. 2023, 16 (1): 8-16
13)- Keisuke Kamada, Atsuhiro Koya, Keitaro Nakanishi, Kazunori Ishikawa, Masami Shingaki, Kiyohumi Morishita. A Novel Graft Route by Passage under the Achilles Tendon in Paramalleolar Distal Bypass Using the Small Saphenous Vein.Annals of vascular diseases. 2023, 16 (1): 86-89
14)- Ryo Yokota, Shun-Ichiro Sakamoto, Tomohiro Murata, Atsushi Hiromoto, Takako Yamaguchi, Kenji Suzuki, Michiko Kobayashi, Shoko Kure, Mitsuhiro Takeno, Yosuke Ishii. A Case of Contained Rupture of the Common Iliac Artery with Idiopathic Retroperitoneal Fibrosis: Efficacy of Surgical Treatment and Immunosuppressive Therapy at 2-Year Follow-Up.Annals of vascular diseases. 2023, 16 (1): 95-99